-
Mashup Score: 0What We’re Reading: Abortion Pill Access Arguments; Clinical Research Site Inspections; AstraZeneca 340B Lawsuit - 1 month(s) ago
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Source: www.ajmc.comCategories: General Medicine News, PayerTweet
What We're Reading: #Abortion Pill Access Arguments; Clinical Research Site Inspections; #AstraZeneca #340B Lawsuit Learn more here: https://t.co/uyLdfg1RbP https://t.co/S96wEcnNUZ